基于CRISPR-Cas9的blaNDM-1基因控制技术的建立及应用研究OA
A CRISPR-Cas9 mediated technology for controlling the blaNDM-1 gene
目的 构建一种整合接合转移元件的成簇规律间隔短回文重复及其相关核酸酶9(CRISPR-Cas9)单质粒系统,并评估其靶向清除不同携带形式耐药基因(ARG)的能力,探索通过接合转移干预ARG水平传播的可行性.方法 设计并筛选靶向blaNDM-1基因的CRISPR-Cas9质粒载体,在此基础上整合oriT-traJ接合转移模块.通过电转化与接合转移实验,评估该系统对不同携带形式的blaNDM-1基因的清除效率.开展药物敏感性实验验证基因编辑菌株耐药性恢复效果.结果 建立的CRISPR-Cas9单质粒系统对基因组、质粒及双位点携带型blaNDM-1基因的清除效率分别达97.9%、87.5%和56.3%.PCR结果证实,本系统经接合转移介导后仍具备靶基因清除能力,可有效逆转细菌耐药性.结论 该单质粒系统可有效清除blaNDM-1基因,恢复细菌对美罗培南的药物敏感性.基于单质粒系统的接合转移递送方式,为清除ARG、恢复受体菌对抗生素的敏感性提供了新的研究工具.
Objective To construct a single-plasmid clustered regularly interspaced short palindromic repeats(CRISPR)/CRISPR-associated nuclease 9(Cas9)single-plasmid system integrated with conjugative transfer elements,evaluate its ability to eliminate antibiotic resistance genes(ARG)harbored by bacteria,and explore the feasibility of containing the dissemination of ARG via conjugative transfer.Methods A CRISPR-Cas9 plasmid vector targeting the blaNDM-1 gene was designed,and the oriT-traJ conjugative transfer module was integrated into the vector backbone.Electrotransformation and conjugative transfer assays were performed to assess the elimination efficiency of this system against blaNDM-1.Antibiotic susceptibility assays were conducted to verify the restoration of antibiotic susceptibility in edited bacterial strains.Results The elimination efficiency of the established CRISPR-Cas9 single-plasmid system was 97.9%,87.5%and 56.3%against blaNDM-1 located on the chromosome,plasmid,and dual location respectively.PCR results demonstrated that the system was still able to eliminate target genes after conjugative transfer and efficiently reversed the antibiotic resistance of recipient bacteria.Conclusion This system can eliminate the blaNDM-1 gene and restore bacterial susceptibility to meropenem.Conjugative transfer delivery mediated by the single-plasmid system provides a novel tool for eradicating ARG and restoring the susceptibility of recipient bacteria to antibiotics.
邵雨桐;金敏;杨栋
军事科学院军事医学研究院,天津 300050军事科学院军事医学研究院,天津 300050军事科学院军事医学研究院,天津 300050
医药卫生
CRISPR-Cas9耐药基因清除效率接合转移再致敏
CRISPR-Cas9antibiotic resistance geneselimination efficiencyconjugationre-sensitization
《军事医学》 2026 (8)
561-569,9
评论